NCT03273127 To Assess the Pharmacokinetics, Safety and Tolerability of Abediterol Administered Once Daily for 9 Days, in Patients With Asthma on Inhaled Corticosteroids Status COMPLETED Phase PHASE1
NCT03272165 Single Ascending Dose Study of MEDI1341 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT03263650 Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPC Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03263637 Study to Assess Safety, Tolerability, Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractory Haematological Malignancies Status COMPLETED Phase PHASE1
NCT03263091 Efficacy and Safety of Roxadustat for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome With Low Red Blood Cell Transfusion Burden Status TERMINATED Phase PHASE3
NCT03259633 An Intermediate Access Protocol for Selumetinib for Treatment of Neurofibromatosis Type 1 Status APPROVED_FOR_MARKETING Phase N/A
NCT03258788 A Translational Study Investigating PD-L1 Expression After Radiotherapy for Non-small Cell Lung Cancer Status COMPLETED Phase N/A
NCT03258515 A Study to Investigate the Effect of Single Dose of AZD6094 (600 mg) on Cardiac Repolarization in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT03249142 Immunotherapy With Neo-adjuvant Chemotherapy for OVarian Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT03248492 A Study of DS-8201a in Metastatic Breast Cancer Previously Treated With Trastuzumab Emtansine (T-DM1) Status TERMINATED Phase PHASE2
NCT03245541 Radiation Therapy in Combination With Durvalumab for People With Pancreatic Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03239340 A Molecular Profiling Study of Patients With EGFR Mutation-positive Locally Advanced or Metastatic NSCLC Treated With Osimertinib Status COMPLETED Phase PHASE2
NCT03237377 Neoadjuvant Immunoradiation for Resectable Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT03236974 Study to Compare the Effects of AZD9496 vs Fulvestrant in Breast Cancer. Status COMPLETED Phase PHASE1
NCT03235050 A Study to Evaluate the Efficacy and Safety of MEDI0382 in the Treatment of Overweight and Obese Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT03234153 Neoadjuvant Immunotherapy With Durvalumab and Tremelimumab for Bladder Cancer Patients Ineligible for Cisplatin Status TERMINATED Phase PHASE2
NCT03229122 Characterizing the Cross-sectional Approach to Ovarian Cancer: Genetic Testing of BRCA Status COMPLETED Phase N/A
NCT03222245 The Effect of Injectable Therapies on Quality of Life in Diabetes Status COMPLETED Phase N/A